Comparison of a baculovirus-based VP2 enzyme immunoassay (EIA) to an Escherichia coli-based VP1 EIA for detection of human parvovirus B19 immunoglobulin M and immunoglobulin G in sera of pregnant women

Journal of Clinical Microbiology

Volumn 38, Issue 4, 2000, Pages 1472-1475

  Jordan, Jeanne A ^a  

^a UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN G; IMMUNOGLOBULIN M;

ANTIBODY DETECTION; ARTICLE; BACULOVIRUS; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; ENZYME IMMUNOASSAY; FEMALE; HUMAN; IMMUNOFLUORESCENCE TEST; IMMUNOGLOBULIN BLOOD LEVEL; INTERMETHOD COMPARISON; NONHUMAN; PARVOVIRUS; PREGNANCY; PRIORITY JOURNAL; VIRUS DETECTION;

CUPRESSUS; DNA VIRUSES; ESCHERICHIA COLI; MIRIDAE; PARVOVIRUS; UNIDENTIFIED BACULOVIRUS;

EID: 0034000143     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/jcm.38.4.1472-1475.2000     Document Type: Article

References (20)

1. Anand, A., E. S. Gray, T. Brown, J. P. Clewley, and B. J. Cohen. 1987. Human parvovirus infection in pregnancy and hydrops fetalis. N. Engl. J. Med. 316:183-186.
2. Andersen, M., P. G. Higgins, L. R. Davis, J. S. Willman, S. E. Jones, I. M. Kidd, J. R. Pattison, and D. A. Tyrrell. 1985. Experimental parvoviral infection in humans. J. Infect. Dis. 152:257-265.
3. Brown, K. E., S. M. Anderson, and N. S. Young. 1993. Erythrocyte P antigen: cellular receptor for B19 parvovirus. Science 262:114-117.
4. Brown, K. E., J. R. Hibbs, G. Gallinella, S. M. Anderson, E. D. Lehman, P. McCarthy, and N. S. Young. 1994. Resistance to parvovirus B19 infection due to lack of virus receptor (erythrocyte P antigen). N. Engl. J. Med. 330:1192-1196.
5. Cohen, B. J., and M. M. Buckley. 1988. The prevalence of antibody to human parvovirus B19 in England and Wales. J. Med. Microhiol. 25:151-153.
6. Cossart, Y., A. M. Field, B. Cant, and D. Widdows. 1975 Parvovirus-like particles in human sera. Lancet i:72-73.
7. Enders, G., and M. Biber. 1990. Parvovirus B19 infections in pregnancy. Behring Inst. Mitt. 85:74-78.
8. Fransilla, R., M. Söderlund, C. S. Brown, W. J. M. Spaan, I. Seppala, and K. Hedman. 1996. IgG subclass response to human parvovirus B19 infection. Clin. Diagn. Virol. 6:41-49.
9. Gratacós, E., P.-J. Torres, J. Vidal, E. Antolín, J. Costa, M. T. Jiménez de Anta, V. Cararach, P. L. Alonso, and A. Fortuny. 1995. The incidence of human parvovirus B19 infection during pregnancy and its impact on perinatal outcome. J. Infect. Dis. 171:1360-1363.
10. Hall, S. M., B. J. Cohen, P. P. Mortimer, E. O. Caul, and J. Cradock-Watson. 1990. Prospective study of human parvovirus (B19) infection in pregnancy. Br. Med. J. 300:1166-1170.
11. Harger, J. H., S. P. Adler, W. C. Koch, and G. F. Harger. 1998. Prospective evaluation of 618 pregnant women exposed to parvovirus B19: risks and symptoms. Obstet. Gynecol. 91:413-420.
12. Jordan, J. A. 1996. Identification of human parvovirus B19 infection in idiopathic nonimmune hydrops fetalis. Am. I. Obstet. Gynecol. 174:37-42.
13. Kajigaya, S., J. Fuji, A. Field, S. Anderson, S. J. Rosenfeld, L. J. Anderson, T. Shimada, and N. S. Young. 1991. Self-assembled B19 parvovirus capsids, produced in a baculovirus system, are antigenically and immunogenically similar to native virions. Proc. Natl. Acad. Sci. USA 88:4646-4650.
14. Kerr, S., G. O'Keeffe, C. Kilty, and S. Doyle. 1999. Undenatured parvovirus B19 antigens are essential for the accurate detection of parvovirus B19 IgG. J. Mod. Virol. 57:179-185.
15. Koch, W. C., and S. P. Adler. 1989. Human parvovirus B19 infections in women of childbearing age and within families. Pediatr. Infect. Dis. 8:83-87.
16. Murphy, F. A., C. M. Fauquet, D. H. L. Bishop, S. A. Ghabrial, A. W. Jarvis, G. P. Martelli, M. A. Mayo, and M. D. Summers (ed.). 1995. Family Parvoviridae, p. 169-178. In Virus taxonomy: classification and nomenclature of viruses. Sixth report of the International Committee on Taxonomy of Viruses. Springer-Verlag. Vienna. Austria.
17. Public Health Laboratory Service Working Party on Fifth Disease. 1990. Prospective study of human parvovirus (1319) infection in pregnancy. Br. Med. J. 300:1166-1170.
18. Rodis, J., T. J. Hovick, Jr., D. L. Quinn, S. S. Rosengren, and P. Tattersall. 1988. Human parvovirus infection in pregnancy. Obstet. Gynecol. 72:733-738.
19. Rudis, J. F., D. L. Quinn, G. W. Gary, Jr., L. J. Anderson, S. Rosengren, M. L. Cartter, W. A. Campbell, and A. M. Vintzileos, 1990. Management and outcomes of pregnancies complicated by human B19 parvovirus infection: a prospective study. Am. J. Obstet. Gynecol. 163:1168-1171.
20. Söderlund, M., C. S. Brown, W. J. Spaan, L. Hedman, and K. Hedman. 1995. Epitope type-specific IgG response to capsid proteins VP1 and VP2 of human parvovirus B19. J. Infect. Dis. 172:1431-1436.